• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吲哚美辛可减弱卡托普利的急性血流动力学和激素效应。

Acute haemodynamic and hormonal effects of captopril are diminished by indomethacin.

作者信息

Witzgall H, Hirsch F, Scherer B, Weber P C

出版信息

Clin Sci (Lond). 1982 Jun;62(6):611-5. doi: 10.1042/cs0620611.

DOI:10.1042/cs0620611
PMID:7044652
Abstract
  1. The acute haemodynamic and hormonal effects of 100 mg of captopril (SQ 14.225) orally were tested in twelve healthy men in the sodium replete state before and after indomethacin pretreatment. 2. Without indomethacin, mean arterial blood pressure was reduced at 30 and 60 min after captopril (P less than 0.02). Heart rate did not change during the whole experiment. Although plasma renin activity (PRA) increased (P less than 0.002), plasma and urinary aldosterone and plasma 18-hydroxycorticosterone (18-OH-B) decreased after captopril (P less than 0.02). Prostaglandin (PG) E2, sodium and potassium excretion rates remained constant after captopril. 3. Under indomethacin pretreatment, the fall in mean arterial blood pressure was less than without indomethacin at 30 and 60 min after captopril (P less than 0.05). Heart rate was constantly lower than without indomethacin during the whole experiment (P less than 0.05). Indomethacin pretreatment decreased basal PGE2 excretion (P less than 0.02) and baseline PRA as well as the increase in PRA after captopril (P less than 0.05). Control mineralocorticoid levels were significantly lower than without indomethacin. In indomethacin-pretreated subjects, aldosterone did not further decrease after captopril, and 18-OH-B fell only slightly. 4. Without indomethacin pretreatment a significant, positive correlation was found between PRA values before captopril and the maximum decrease of mean arterial blood pressure after captopril. Under indomethacin pretreatment this correlation was no longer demonstrable. The results suggest that prostaglandins may contribute to the haemodynamic and hormonal actions of captopril.
摘要
  1. 对12名处于钠充足状态的健康男性,在吲哚美辛预处理前后口服100毫克卡托普利(SQ 14.225),测试其急性血液动力学和激素效应。2. 未用吲哚美辛时,卡托普利给药后30和60分钟平均动脉血压降低(P<0.02)。整个实验过程中心率未变。虽然血浆肾素活性(PRA)升高(P<0.002),但卡托普利给药后血浆和尿醛固酮以及血浆18 - 羟皮质酮(18 - OH - B)降低(P<0.02)。卡托普利给药后前列腺素(PG)E2、钠和钾排泄率保持恒定。3. 在吲哚美辛预处理下,卡托普利给药后30和60分钟平均动脉血压的下降幅度小于未用吲哚美辛时(P<0.05)。整个实验过程中心率持续低于未用吲哚美辛时(P<0.05)。吲哚美辛预处理降低了基础PGE2排泄(P<0.02)以及基线PRA和卡托普利给药后PRA的升高幅度(P<0.05)。对照盐皮质激素水平显著低于未用吲哚美辛时。在吲哚美辛预处理的受试者中,卡托普利给药后醛固酮未进一步降低,18 - OH - B仅略有下降。4. 未用吲哚美辛预处理时,发现卡托普利给药前的PRA值与卡托普利给药后平均动脉血压的最大下降幅度之间存在显著正相关。在吲哚美辛预处理下,这种相关性不再明显。结果表明,前列腺素可能参与了卡托普利的血液动力学和激素作用。

相似文献

1
Acute haemodynamic and hormonal effects of captopril are diminished by indomethacin.吲哚美辛可减弱卡托普利的急性血流动力学和激素效应。
Clin Sci (Lond). 1982 Jun;62(6):611-5. doi: 10.1042/cs0620611.
2
Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure.
Cardiology. 1983;70(6):297-307. doi: 10.1159/000173612.
3
A simultaneous radioimmunoassay for aldosterone and its precursors: human plasma levels following the inhibition of converting enzyme, before and after blockade of prostaglandin biosynthesis.醛固酮及其前体的同步放射免疫分析:前列腺素生物合成阻断前后,转换酶抑制后的人体血浆水平。
J Clin Chem Clin Biochem. 1981 Jun;19(6):387-94. doi: 10.1515/cclm.1981.19.6.387.
4
Effects of captopril on arterial and venous pressure, renal function, and humoral factors in severe chronic congestive heart failure.卡托普利对重度慢性充血性心力衰竭患者动脉压、静脉压、肾功能及体液因子的影响
Clin Pharmacol Ther. 1984 Oct;36(4):456-63. doi: 10.1038/clpt.1984.204.
5
[Renin and aldosterone secretion under converting enzyme inhibition].[转化酶抑制下的肾素和醛固酮分泌]
Nihon Naibunpi Gakkai Zasshi. 1983 Aug 20;59(8):1099-116. doi: 10.1507/endocrine1927.59.8_1099.
6
Role of prostaglandin in the antihypertensive mechanism of captopril in low renin hypertension.
Clin Sci (Lond). 1980 Dec;59 Suppl 6:141s-144s. doi: 10.1042/cs059141s.
7
Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers.血管紧张素转换酶抑制剂卡托普利对血压正常且钠储备充足的志愿者的影响。
J Cardiovasc Pharmacol. 1982 May-Jun;4(3):381-7. doi: 10.1097/00005344-198205000-00007.
8
Single-dose captopril administration in DOCA/salt rats: reduction of hypotensive effect by indomethacin.在去氧皮质酮盐(DOCA)/盐大鼠中单次给予卡托普利:消炎痛降低其降压效果。
Clin Exp Hypertens (1978). 1980;2(6):935-45. doi: 10.3109/10641968009037152.
9
Renal response to captopril in conscious dogs pretreated with indomethacin.
Am J Physiol. 1982 Dec;243(6):G543-8. doi: 10.1152/ajprenal.1982.243.6.F543.
10
Peripheral hemodynamic effects of captopril in patients with congestive heart failure.
Am Heart J. 1989 Jan;117(1):100-5. doi: 10.1016/0002-8703(89)90662-5.

引用本文的文献

1
Cardioprotective Role of Captopril: From Basic to Applied Investigations.卡托普利的心脏保护作用:从基础研究到应用研究
Int J Mol Sci. 2025 Jul 25;26(15):7215. doi: 10.3390/ijms26157215.
2
Arachidonic acid metabolites, hypertension and arteriosclerosis.花生四烯酸代谢产物、高血压与动脉硬化
Klin Wochenschr. 1982 May 17;60(10):479-88. doi: 10.1007/BF01756093.
3
Inhibitors of the angiotensin I converting enzyme as antihypertensive drugs.作为抗高血压药物的血管紧张素I转换酶抑制剂。
Pharm Weekbl Sci. 1983 Oct 21;5(5):197-204. doi: 10.1007/BF02332943.
4
Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.卡托普利:关于其药理特性及在充血性心力衰竭中治疗效果的最新综述
Drugs. 1983 Jan;25(1):6-40. doi: 10.2165/00003495-198325010-00002.
5
[Eicosanoids and phospholipases].[类二十烷酸与磷脂酶]
Klin Wochenschr. 1985 Apr 1;63(7):293-311. doi: 10.1007/BF01731973.
6
Do nonsteroidal anti-inflammatory drugs interfere with blood pressure control in hypertensive patients?
J Gen Intern Med. 1987 Mar-Apr;2(2):108-12. doi: 10.1007/BF02596307.
7
Angiotensin inhibitors and other vasodilators with special reference to congestive heart failure.血管紧张素抑制剂及其他血管扩张剂,特别提及充血性心力衰竭
Cardiovasc Drugs Ther. 1987;1(1):1-8. doi: 10.1007/BF02125827.
8
Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.卡托普利。其药效学和药代动力学特性的最新进展,以及在高血压和充血性心力衰竭中的治疗应用。
Drugs. 1988 Nov;36(5):540-600. doi: 10.2165/00003495-198836050-00003.
9
Acute and chronic effects of angiotensin converting enzyme inhibitors on the essential hypertensive kidney.血管紧张素转换酶抑制剂对原发性高血压肾脏的急性和慢性影响。
Cardiovasc Drugs Ther. 1990 Feb;4(1):207-19. doi: 10.1007/BF01857635.
10
Studies on the effect of two angiotensin-converting enzyme inhibitors, captopril and cilazapril, on platelet and vascular prostaglandin metabolism in vivo.关于两种血管紧张素转换酶抑制剂卡托普利和西拉普利对体内血小板和血管前列腺素代谢影响的研究。
Naunyn Schmiedebergs Arch Pharmacol. 1992 Oct;346(4):453-6. doi: 10.1007/BF00171089.